The treatment of induced immune deficiency with interleukin-2
- 1 January 1985
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 10 (6) , 307-314
- https://doi.org/10.1016/0165-2478(85)90123-3
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Lymphokine purification by reversed-phase high-performance liquid chromatographyJournal of Chromatography A, 1984
- Expansion of cyclophosphamide-resistant cytotoxic precursors in vitro and in vivo by purified human interleukin 2.The Journal of Immunology, 1983
- Corticosteroid‐Mediated Immunoregulation in ManImmunological Reviews, 1982
- Effect of Cyclophosphamide on Immunological Control MechanismsImmunological Reviews, 1982
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu miceNature, 1980
- The in vitro generation and sustained culture of nude mouse cytolytic T-lymphocytes.The Journal of Experimental Medicine, 1979
- Differential cyclophosphamide sensitivity of precursor cells in allogeneic and H-2 restricted cytotoxic responses.The Journal of Experimental Medicine, 1979
- T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for ActivityThe Journal of Immunology, 1978
- Bone Marrow and Spleen: Dissociation of Immunologic Properties by CortisoneScience, 1970